ASX-listed, Singapore-based ACLDT formalises partnership with US healthcare giant UPMC to set up Comprehensive Transplant Centre
Singapore, Oct. 29, 2012 – Singapore-based and Australia-listed Asian Centre for Liver Diseases & Transplantation (“ACLDT”), announced today it has formalised an agreement with The University of Pittsburgh Medical Center (“UPMC”), a US$10-billion integrated global health enterprise headquartered in Pittsburgh, U.S.A, to develop a Comprehensive Transplant Centre (“CTC”) in Singapore to treat liver, kidney, stem cells and bone marrow diseases.
The Asian American Medical Group Inc. (“AAMG”, formerly known as ACLDT Inc.), a wholly-owned subsidiary of ACLDT, entered into agreement with the world-renowned UPMC, under which UPMC will provide specialised services needed to set up such a CTC while AAMG will spearhead the development of the AAMG and UPMC collaboration in Asia and beyond.
The formal agreement comes nearly nine months after an interim service agreement between UPMC and ACLDT, following which UPMC began sharing its advanced medical expertise and technologies, including telemedicine, electronic medical records and management skills, with ACLDT, which operates out of Gleneagles Hospital in Singapore.
ACLDT is one of Asia’s foremost Liver Centres with outpatient facilities and a dedicated in-patient Liver Ward and Intensive Care Unit (“ICU”) to complement its successful Living Donor Liver Transplantation (“LDLT”) Programme, thus providing seamless care for patients with liver diseases. It is the first private medical centre in South-east Asia to have performed 200 LDLTs.
The agreement with UPMC is part of ACLDT’s strategic direction to offer specialised treatment and transplantations for organs other than the liver, and to develop a full-fledged CTC in Singapore to serve the pan-Asia and Middle East markets. The CTC will specialise in transplant immunology, transplant, infectious diseases and ICU of immune-suppressed patients.
In line with the development of the CTC, AAMG plans to set up a centre for stem cell and bone marrow transplantation at Gleneagles Hospital under its wholly-owned subsidiary, Asian Centre for Blood and Bone Marrow Transplantation Pte Ltd (formally known as ALC Management Consultancy Pte Ltd). A Haematologist will be recruited to oversee the clinical and operational aspects of the new centre and, together with a new team of trained and experienced nursing staff, will commence work early next year.
Under the agreement UPMC will assist AAMG in expanding its current capacity to provide clinical services for patients, as well as with clinical and translational research. UPMC and AAMG will collaborate in the planning and design of the CTC. UPMC will continue to assist AAMG with the clinical service programmes for the areas of collaboration offered by the CTC.
UPMC and AAMG may extend services beyond the CTC Hub in Singapore through “spokes” to establish a clinical network in South-east Asia and other countries. Such spokes will serve as diagnostic/referral/post discharge patient centres, or refer patients to the Singapore-based CTC Hub.
UPMC, with renowned centres of excellence in transplantation, cancer, neurosurgery, psychiatry, rehabilitation, geriatrics, and women’s health, is ranked No. 10 among “America’s Best Hospitals” by U.S. News & World Report. UPMC’s Thomas E. Starzl Transplantation Institute in Pittsburgh is considered a pioneer in solid organ transplant procedures and it has performed more than 17,000 such operations, including liver, heart, kidney, multi-visceral and hand. UPMC’s Istituto Mediterraneo per i Trapianti e Terapie di Alta Specializzazione (“ISMETT”) in Sicily is one of the leading organ transplant centres in Italy and the Mediterranean.
UPMC will provide the hub-and-spoke services which will include, but are not limited to, assistance in planning and implementing the expansion of existing and new clinical activities and programmes related to the collaboration, support of day-to-day clinical services, assistance in establishing quality control and improvement initiatives, and assistance in planning and implementing educational programmes.